Home

TLDR Biotech

The top stories in biotech & pharma, straight to your inbox in only one email.
Trusted by 3000+ biotech and pharma professionals.

Comprehensive daily coverage of the biotech and pharma industry, straight to your inbox.

TLDR Biotech

The Latest Biotech & Pharma Updates

The Most Skeptical Buyer - Selling To Scientists

May 30, 2026

•

8 min read

The Most Skeptical Buyer - Selling To Scientists

Selling to Scientists & Technical Industries

Anis Fahandej-Sadi

May 29, 2026

•

3 min read

Biotech & Pharma Updates | May 29, 2026

🧬 Pfizer, Innovent Biologics strike $10B cancer deal covering 12 ADC and multispecific antibody programs, $650M upfront, AstraZeneca's Imfinzi (durvalumab) wins FDA approval for BCG-naïve high-risk non-muscle-invasive bladder cancer after Ph3 win, Replimune resubmits RP1 melanoma BLA for third time following major FDA leadership shakeup

Christian Cuchapin, +1

May 28, 2026

•

3 min read

Biotech & Pharma Updates | May 28, 2026

🧬 GSK, Ionis Pharmaceuticals' (bepirovirsen) achieves Ph3 functional cure in nearly 20% of chronic hepatitis B patients, AbbVie's Decnupaz wins FDA approval for blastic plasmacytoid dendritic cell neoplasm, targeting CD123 in Ph1/2, Secretome Therapeutics raises $30M Series A to advance cardiac cell therapies pipeline

Christian Cuchapin, +1

May 27, 2026

•

3 min read

Biotech & Pharma Updates | May 27, 2026

🧬 Outlook Therapeutics' Lytenava (bevacizumab) gains FDA appeal win for wet age-related macular degeneration, AstraZeneca's (camizestrant) FDA review delayed after advisory committee rejects Ph3 data for HR-positive breast cancer, Astellas unveils five-year growth strategy to offset Xtandi patent expiry through pipeline acquisitions

Christian Cuchapin, +1

Biotech & Pharma Updates | May 21 - 26, 2026

May 26, 2026

•

3 min read

Biotech & Pharma Updates | May 21 - 26, 2026

🧬 Eli Lilly to acquire Curevo, LimmaTech Biologics, and Vaccine Company for up to $3.8B to build infectious disease pipeline

Christian Cuchapin, +1

Biotech & Pharma Updates | May 20 - 21, 2026

May 22, 2026

•

3 min read

Biotech & Pharma Updates | May 20 - 21, 2026

🧬 Eli Lilly's (retatrutide) Ph3 TRIUMPH-1 delivers bariatric surgery–level weight loss in obesity patients, Research Alliance III raises $75M SPAC IPO, targeting China-based biotech merger, Merck & Co., Kelun-Biotech's (sacituzumab tirumotecan) plus Keytruda cuts progression risk 65% in Ph3 non-small cell lung cancer

Christian Cuchapin, +1

Biotech & Pharma Updates | May 19 - 20, 2026

May 21, 2026

•

3 min read

Biotech & Pharma Updates | May 19 - 20, 2026

🧬 Parabilis Medicines files for IPO after raising $800M, targeting "undruggable" oncology proteins, Eli Lilly acquires Engage Bio for up to $202M to expand nonviral DNA delivery platform, Bristol Myers Squibb, Anthropic partner to deploy Claude AI across drug development operations

Christian Cuchapin, +1

Biotech & Pharma Updates | May 18 - 19, 2026

May 20, 2026

•

3 min read

Biotech & Pharma Updates | May 18 - 19, 2026

🧬 UCB's Bimzelx (bimekizumab) outperforms Skyrizi in Ph3 head-to-head trial for psoriatic arthritis, Incyte, Edison Scientific partner to deploy Kosmos AI across drug discovery and R&D workflows, Mentari Therapeutics goes public via reverse merger with InMed Pharmaceuticals, raising $290M for migraine pipeline

Christian Cuchapin, +1

Biotech & Pharma Updates | May 17 - 18, 2026

May 19, 2026

•

4 min read

Biotech & Pharma Updates | May 17 - 18, 2026

🧬 Bristol Myers Squibb weighs $1B Houston manufacturing plant that could employ 500 people, Merck & Co.'s (sacituzumab tirumotecan) hits Ph3 mark in endometrial cancer, beating chemotherapy in survival outcomes, Full-Life Technologies raises $150M Series D, advancing radiotherapeutics pipeline and Belgium manufacturing

Christian Cuchapin, +1

...

The Latest Biotech & Pharma Updates

The Most Skeptical Buyer - Selling To Scientists

Biotech & Pharma Updates | May 29, 2026

Biotech & Pharma Updates | May 28, 2026

Biotech & Pharma Updates | May 27, 2026

Biotech & Pharma Updates | May 21 - 26, 2026

Biotech & Pharma Updates | May 20 - 21, 2026

Biotech & Pharma Updates | May 19 - 20, 2026

Biotech & Pharma Updates | May 18 - 19, 2026

Biotech & Pharma Updates | May 17 - 18, 2026

TLDR Biotech

FAQ

Media Partners